These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36559158)

  • 1. Inhibition of Liquid-Liquid Phase Separation for Breaking the Solubility Barrier of Amorphous Solid Dispersions to Improve Oral Absorption of Naftopidil.
    Fukiage M; Suzuki K; Matsuda M; Nishida Y; Oikawa M; Fujita T; Kawakami K
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions.
    Suzuki K; Kawakami K; Fukiage M; Oikawa M; Nishida Y; Matsuda M; Fujita T
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
    Butreddy A
    Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High drug loading nanosized amorphous solid dispersion (NASD) with enhanced in vitro solubility and permeability: Benchmarking conventional ASD.
    Andrews GP; Qian K; Jacobs E; Jones DS; Tian Y
    Int J Pharm; 2023 Feb; 632():122551. PubMed ID: 36581107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot-melt extruded hydroxypropyl methylcellulose acetate succinate based amorphous solid dispersions: Impact of polymeric combinations on supersaturation kinetics and dissolution performance.
    Butreddy A; Sarabu S; Almutairi M; Ajjarapu S; Kolimi P; Bandari S; Repka MA
    Int J Pharm; 2022 Mar; 615():121471. PubMed ID: 35041915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric Polymer-Based Amorphous Solid Dispersions Enhance Oral Absorption of the Weakly Basic Drug Nintedanib via Stabilization of Supersaturation.
    Qin Y; Xiao C; Li X; Huang J; Si L; Sun M
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport.
    Wilson V; Lou X; Osterling DJ; Stolarik DF; Jenkins G; Gao W; Zhang GGZ; Taylor LS
    J Control Release; 2018 Dec; 292():172-182. PubMed ID: 30408553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole.
    Monschke M; Kayser K; Wagner KG
    AAPS PharmSciTech; 2021 Jan; 22(1):44. PubMed ID: 33438107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
    Trasi NS; Taylor LS
    Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD; Pinto JF; Henriques J; Paiva AM
    Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
    Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.